STB
BMY icon

S&T Bank’s Bristol-Myers Squibb BMY Stock Holding History

S&T Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
2,458
+542
+28% +$31.1K 0.04% 129
2026
Q1 		$116K Buy
1,916
+29
+2% +$1.69K 0.04% 125
2025
Q4 		$102K Sell
1,887
-86
-4% -$4.14K 0.03% 134
2025
Q3 		$89K Sell
1,973
-257
-12% -$12K 0.03% 144
2025
Q2 		$103K Hold
2,230
– – 0.03% 129
2025
Q1 		$136K Buy
2,230
+343
+18% +$20K 0.04% 117
2024
Q4 		$107K Buy
+1,887
New +$105K 0.03% 118

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

S&T Bank's BMY Position: Q2 2026 in Review

S&T Bank increased its Bristol-Myers Squibb (BMY) stake by 28% in Q2 2026, buying an estimated $31.1K and bringing the position to 2,458 shares worth $142K. The position accounts for 0.04% of the portfolio, ranked #129.

S&T Bank first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • S&T Bank held 2,458 shares of Bristol-Myers Squibb worth $142K as of Q2 2026.
  • S&T Bank bought 542 Bristol-Myers Squibb shares in Q2 2026, an estimated $31.1K.
  • Bristol-Myers Squibb made up 0.04% of S&T Bank's portfolio in Q2 2026, its #129 holding.
  • S&T Bank first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.